Search results
Results from the WOW.Com Content Network
Acute bronchitis, also known as a chest cold, is short-term bronchitis – inflammation of the bronchi (large and medium-sized airways) of the lungs. [2] [1] The most common symptom is a cough. [1] Other symptoms include coughing up mucus, wheezing, shortness of breath, fever, and chest discomfort. [2] The infection may last from a few to ten ...
The infection then makes its way down to the bronchi. Symptoms include coughing up sputum, wheezing, shortness of breath, and chest pain. Bronchitis can be acute or chronic. [1] Acute bronchitis usually has a cough that lasts around three weeks, [4] and is also known as a chest cold. [5] In more than 90% of cases, the cause is a viral infection ...
Along with a runny nose and sore throat, green phlegm is another cold-like symptom of COVID-19. Interestingly, the color of the mucus is an important indicator when it comes to infection.
Having green, yellow, or thickened phlegm (sputum) does not always indicate the presence of an infection. Also, if an infection is present, the color of the phlegm (sputum) does not determine whether a virus, a bacterium or another pathogen has caused it. Simple allergies can also cause changes in the color of the mucus. [1]
A postinfectious cough is a lingering cough that follows a respiratory tract infection, such as a common cold or flu and lasting up to eight weeks. Postinfectious cough is a clinically recognized condition represented within the medical literature.
Up to half of those with Legionnaires' disease have gastrointestinal symptoms, and almost half have neurological symptoms, [16] including confusion and impaired cognition. [ 17 ] [ 18 ] "Relative bradycardia " may also be present, which is low to normal heart rate despite the presence of a fever.
A study found that 9.4% of global deaths between 2000 and 2019 – ~5 million annually – can be attributed to extreme temperature with cold-related ones making up the larger share and decreasing and heat-related ones making up ~0.91% and increasing. Incidences of heart attacks, cardiac arrests and strokes increase under such conditions.
A journal report from 1983 indicated that untreated DPB had a five-year survival rate of 62.1%, while the 10-year survival rate was 33.2%. [6] With erythromycin treatment, individuals with DPB now have a much longer life expectancy due to better management of symptoms, delay of progression, and prevention of associated infections like P ...